Document:

EX-4.3

 Exhibit 4.3 

This FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), effective as of November 6, 2017, between NAVISTAR
INTERNATIONAL CORPORATION, a Delaware corporation (the “Company”) and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee (the “Trustee”), under the Indenture, dated as of October 28, 2009, as amended to date (the
“Indenture”). Capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the Indenture. 

WITNESSETH: 

WHEREAS, the Company has issued its 8.25% Senior Notes due 2021 (the “Notes”) pursuant to the Indenture; 

WHEREAS, the Company has offered to purchase for cash any and all outstanding Notes (the “Tender Offer”); 

WHEREAS, in connection with the Tender Offer, the Company has requested that Holders of the Notes deliver their consents with respect
to the deletion or amendment of certain provisions of the Indenture; 
 WHEREAS, Section 9.2 of the Indenture provides that the
Company and the Trustee may amend or supplement the Indenture, the Notes and the Guarantees with the consent of the Holders of at least a majority in aggregate principal amount of the then outstanding Notes (including, without limitation, consents
obtained in connection with a tender offer or exchange offer for, or purchase of, the Notes); 
 WHEREAS, the Holders of at least a
majority in aggregate principal amount of the outstanding Notes have duly consented to the proposed modifications set forth in this Supplemental Indenture in accordance with the Indenture (including Section 9.2 thereof); 

WHEREAS, the Company has heretofore delivered, or is delivering contemporaneously herewith, to the Trustee (i) a copy of
resolutions of the Board of Directors of the Company authorizing the execution of this Supplemental Indenture, (ii) evidence of the consent of the Holders set forth in the immediately preceding paragraph and (iii) the Officers’
Certificate described in Section 11.4 of the Indenture and the Opinion of Counsel described in Sections 9.4 and 11.4 of the Indenture; and 

WHEREAS, all conditions necessary to authorize the execution and delivery of this Supplemental Indenture and to make this Supplemental
Indenture valid and binding have been complied with or have been done or performed. 
 NOW, THEREFORE, in consideration of the
foregoing and notwithstanding any provision of the Indenture which, absent this Supplemental Indenture, might operate to limit such action, the parties hereto, intending to be legally bound hereby, agree as follows: 

ARTICLE ONE 
 AMENDMENTS 

SECTION 1.01  Amendments. 

(a)        Subject to Section 2.02 hereof, the Indenture is hereby amended by
deleting in their entireties Sections 3.6, 3.9, 3.10, 3.12, 3.13, 3.14, 3.15, 3.16, 3.17, 4.1(a)(ii), 5.9, 6.1(e) and 6.1(f) of the Indenture. 

(b)        Subject to Section 2.02 hereof, the Indenture is hereby amended by
deleting the first sentence of Section 5.4 and replacing it in its entirety with the following sentence: 
 At least 5 days but no more
than 60 days before any redemption date the Company will deliver written notice of such redemption to the Trustee and deliver a notice of redemption to each holder of Securities to be redeemed at its registered address. 

(c)        Effective as of the date hereof, none of the Company, the Guarantor, the
Trustee or other parties to or beneficiaries of the Indenture shall have any rights, obligations or liabilities under such Sections or Clauses 

 
and such Sections or Clauses shall not be considered in determining whether an Event of Default has occurred or whether the Company or the Guarantor has observed, performed or complied with the
provisions of the Indenture. 
 SECTION 1.02  Amendment of Definitions. Subject to Section 2.02 hereof, the
Indenture is hereby amended by deleting any definitions from the Indenture with respect to which references would be eliminated as a result of the amendments of the Indenture pursuant to Section 1.01 hereof. 

ARTICLE TWO 
 MISCELLANEOUS 

SECTION 2.01  Effect of Supplemental Indenture. Except as amended hereby, all of the terms of the Indenture shall
remain and continue in full force and effect and are hereby confirmed in all respects. From and after the date of this Supplemental Indenture, all references to the Indenture (whether in the Indenture or in any other agreements, documents or
instruments) shall be deemed to be references to the Indenture as amended and supplemented by this Supplemental Indenture. 
 SECTION
2.02  Effectiveness. The provisions of this Supplemental Indenture shall be effective only upon execution and delivery of this instrument by the parties hereto. Notwithstanding the foregoing sentence, the provisions of this
Supplemental Indenture shall become operative only upon the purchase by the Company of at least a majority in principal amount of the outstanding Notes pursuant to the Tender Offer, with the result that the amendments to the Indenture effected by
this Supplemental Indenture shall be deemed to be revoked retroactively to the date hereof if such purchase shall not occur. 
 SECTION
2.03  Governing Law. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE. 

SECTION 2.04  No Representations by Trustee. The recitals contained herein shall be taken as the statements of the
Company and the Trustee assumes no responsibility for the correctness or completeness of the same. The Trustee makes no representations as to the validity or sufficiency of this Supplemental Indenture. 

SECTION 2.05  Counterparts. This Supplemental Indenture may be executed in any number of counterparts, each of which
shall be an original; but such counterparts shall constitute but one and the same instrument. 
 (Signature page follows) 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date hereof. 
  

			
	ISSUER:
	NAVISTAR INTERNATIONAL CORPORATION
		
	By:	 	/s/ William V. McMenamin
	Name:	 	William V. McMenamin
	Title:	 	President, Financial Services and Treasurer
	
	TRUSTEE:
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	/s/ Lawrence M. Kusch
	Name:	 	Lawrence M. Kusch
	Title:	 	Vice PresidentEX-10.1

 Exhibit 10.1 

[EXECUTION VERSION] 

$1,100,000,000 
 NAVISTAR
INTERNATIONAL CORPORATION 
 6.625% Senior Notes due 2025 

Purchase Agreement 

November 2, 2017 
 J.P. Morgan Securities LLC

   As Representative of the 
   several
Initial Purchasers listed 
   in Schedule 1 hereto 

c/o J.P. Morgan Securities LLC 
 383 Madison Avenue 

New York, New York 10179 
 Ladies and Gentlemen: 

Navistar International Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several initial
purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $1,100,000,000 aggregate principal amount of its 6.625% Senior Notes due 2025 (the
“Securities”). The Securities will be issued pursuant to an indenture to be dated as of November 6, 2017 (the “Indenture”) among the Company, the Guarantor (as defined below) and The Bank of New York Mellon
Trust Company, N.A., as trustee (the “Trustee”), and will be guaranteed on a senior unsecured basis by Navistar, Inc., a Delaware corporation (the “Guarantor” and such guarantee, the “Guarantee”).

 The Company and the Guarantor hereby confirm their agreement with the several Initial Purchasers concerning the purchase and resale of
the Securities, as follows: 
 The Securities will be sold to the Initial Purchasers without being registered under the Securities Act of
1933, as amended (the “Securities Act”), in reliance upon an exemption therefrom. The Company has prepared a preliminary offering memorandum dated November 2, 2017 (the “Preliminary Offering Memorandum”), and
will prepare an offering memorandum dated the date hereof (the “Offering Memorandum”), setting forth information concerning the Company and the Securities. Copies of the Preliminary Offering Memorandum have been, and copies of the
Offering Memorandum will be, delivered by the Company to the Initial Purchasers pursuant to the terms of this purchase agreement (the “Agreement”). The Company hereby confirms that it has authorized the use of the Preliminary
Offering Memorandum, the other Time of Sale Information (as defined below) and the Offering Memorandum in connection with the offering and resale of the Securities by the Initial Purchasers in the manner contemplated by this Agreement. References
herein to the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum shall be deemed to refer to and include any 

  
 2 

 document incorporated by reference therein and any reference to “amend,” “amendment” or
“supplement” with respect to the Preliminary Offering Memorandum or the Offering Memorandum shall be deemed to refer to and include any documents filed on or after such date and incorporated by reference therein. Capitalized terms used but
not defined herein shall have the meanings given to such terms in the Preliminary Offering Memorandum. 
 At or prior to the time when sales
of the Securities were first made (the “Time of Sale”), the Company had prepared the following information (collectively, the “Time of Sale Information”): the Preliminary Offering Memorandum, as supplemented and
amended by the written communications listed on Annex A hereto. 
 On November 6, 2017, the Company expects to obtain the Recovery Zone
Facility Bonds Amendment (as defined below) that, among other things, will permit the Company to consummate the Transactions (as defined below). On or prior to the Closing Date, the Company will execute and deliver the Term Loan Credit Agreement (as
defined below), the proceeds of which will be used to (i) partially finance the Tender Offer (as defined below) and (ii) repay in full all outstanding indebtedness, pay accrued and unpaid interest, fees and expenses, and terminate all
commitments, under its existing senior secured term loan facility. Pursuant to the Offer to Purchase and Consent Solicitation, dated October 20, 2017 (the “Offer to Purchase”), the Company has commenced an offer to purchase any and
all of the Company’s 8.25% Senior Notes due 2021 (the “Existing Notes”) and the solicitation of consents to proposed amendments to the indenture governing the Existing Notes (such offer and solicitation, the “Tender Offer”).
The Company will use a portion of the proceeds of the Term Loan Credit Agreement and use all of the proceeds of the Securities (x) to pay the Total Consideration (as defined in the Offer to Purchase) to each holder of Existing Notes who has
validly tendered and not withdrawn Existing Notes prior to the Early Tender Expiration (as defined in the Offer to Purchase) and (y) redeem any Existing Notes that remain outstanding after the Early Tender Time in accordance with the terms of
the indenture governing the Existing Notes (the “Redemption”). In this Agreement, the execution and delivery of the Recovery Zone Facility Bonds Amendment, the execution and delivery of the Term Loan Credit Agreement and the use of
proceeds thereof, the offering and sale of the Securities and the Guarantees and the use of proceeds thereof, the Tender Offer, the Redemption and the other transactions contemplated thereby, all as described in the Time of Sale Information and the
Offering Memorandum, are collectively referred to as the “Transactions.” 

1.        Purchase and Resale of the Securities. 

(a)      The Company agrees to issue and sell the Securities to the several Initial Purchasers as provided in
this Agreement, and each Initial Purchaser, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the Company the
respective principal amount of Securities set forth opposite such Initial Purchaser’s name in Schedule 1 hereto at a price equal to 98.75% of the principal amount thereof (the “Purchase Price”) plus accrued interest, if any,
from November 6, 2017 to the Closing Date (as defined below). The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein. 

  
 3 

 (b)        The Company understands that the Initial
Purchasers intend to offer the Securities for resale on the terms set forth in the Time of Sale Information. Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that: 

(i)        it is a qualified institutional buyer within the meaning of Rule 144A under
the Securities Act (a “QIB”) and an accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act (“Regulation D”); 

(ii)        it has not solicited offers for, or offered or sold, and will not solicit
offers for, or offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of
Section 4(a)(2) of the Securities Act; and 
 (iii)        it has not solicited
offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities as part of their initial offering except (x) to persons whom it reasonably believes to be QIBs in transactions pursuant to Rule 144A under the
Securities Act (“Rule 144A”) and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the Securities is aware that such sale is being made in reliance on Rule 144A or
(y) outside the United States in accordance with the restrictions set forth in Annex C. 

(c)        Each Initial Purchaser acknowledges and agrees that the Company and, for purposes of the
“no registration” opinions to be delivered to the Initial Purchasers pursuant to Sections 6(f) and 6(h), counsel for the Company and counsel for the Initial Purchasers, respectively, may rely upon the accuracy of the representations and
warranties of the Initial Purchasers, and compliance by the Initial Purchasers with their agreements, contained in paragraph (b) above (including Annex C), and each Initial Purchaser hereby consents to such reliance. 

(d)        The Company acknowledges and agrees that the Initial Purchasers may offer and sell
Securities to or through any affiliate of an Initial Purchaser and that any such affiliate may offer and sell Securities purchased by it to or through any Initial Purchaser. 

(e)        The Company and the Guarantor acknowledge and agree that each Initial Purchaser is acting
solely in the capacity of an arm’s length contractual counterparty to the Company and the Guarantor with respect to the offering of Securities contemplated hereby (including in connection with determining the terms of the offering) and not as a
financial advisor or a fiduciary to, or an agent of, the Company, the Guarantor or any other person. Additionally, none of the Representative or any other Initial Purchaser is advising the Company, the Guarantor or any other person as to any legal,
tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Guarantor shall consult with their own advisors concerning such matters and shall be responsible for making their own independent investigation and appraisal
of the transactions contemplated hereby, and none of the Representative or any other Initial Purchaser shall 

  
 4 

 have any responsibility or liability to the Company or the Guarantor with respect thereto. Any review by the
Representative or any Initial Purchaser of the Company, the Guarantor, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Representative or such Initial Purchaser, as
the case may be, and shall not be on behalf of the Company, the Guarantor or any other person. 

2.        Payment and Delivery. 

(a)        Payment for and delivery of the Securities shall be made at the offices of Cravath,
Swaine & Moore LLP at 10:00 A.M., New York City time, on November 6, 2017, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representative and the Company may agree
upon in writing. The time and date of such payment and delivery for the Securities is referred to herein as the “Closing Date”. 

(b)        Payment for the Securities to be purchased on the Closing Date shall be made by wire
transfer in immediately available funds to the account specified by the Company to the Representative against delivery to the nominee of The Depository Trust Company (“DTC”), for the respective accounts of the several Initial
Purchasers of the Securities to be purchased on the Closing Date, of one or more global notes representing the Securities (collectively, the “Global Note”), with any transfer taxes payable in connection with the sale of such
Securities duly paid by the Company. A copy of the Global Note will be made available for inspection by the Representative at the office of Cravath, Swaine & Moore LLP not later than 1:00 P.M., New York City time, on the business day prior
to the Closing Date. 
 3.        Representations and Warranties of the Company and the
Guarantor. The Company and the Guarantor jointly and severally represent and warrant to each Initial Purchaser that: 

(a)        Preliminary Offering Memorandum, Time of Sale Information and Offering Memorandum.
The Preliminary Offering Memorandum, as of its date, did not, the Time of Sale Information, at the Time of Sale, did not, and at the Closing Date, will not, and the Offering Memorandum, in the form first used by the Initial Purchasers to confirm
sales of the Securities and as of the Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading; provided that the Company and the Guarantor make no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Initial Purchaser
furnished to the Company and the Guarantor in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, the Time of Sale Information or the Offering Memorandum, it being understood and
agreed that the only such information furnished by any Initial Purchaser consists of the information described as such in Section 7(b) hereof. 

  
 5 

 (b)        Additional Written
Communications.  The Company and the Guarantor (including their respective agents and representatives, other than the Initial Purchasers in their capacity as such) have not prepared, made, used, authorized, approved or referred to and
will not prepare, make, use, authorize, approve or refer to any “written communication” (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such
communication by the Company or the Guarantor or their respective agents and representatives (other than a communication referred to in clauses (i) and (ii) below) an “Issuer Written Communication”) other than (i) the
Preliminary Offering Memorandum, (ii) the Offering Memorandum, (iii) the documents listed on Annex A hereto, including a term sheet substantially in the form of Annex B hereto (the “Pricing Supplement”), which constitute
part of the Time of Sale Information, and (iv) any electronic road show and any other written communications approved in writing in advance by the Representative, in each case used in accordance with Section 4(c). Each such Issuer Written
Communication, when taken together with the Time of Sale Information at the Time of Sale, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company and the Guarantor make no representation or warranty with respect to any statements or omissions made in each such
Issuer Written Communication in reliance upon and in conformity with information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in any Issuer Written
Communication, it being understood and agreed that the only such information furnished by any Initial Purchaser consists of the information described as such in Section 7(b) hereof. 

(c)        Incorporated Documents. The documents incorporated by reference in each of the Time
of Sale Information and the Offering Memorandum, when they were filed with the Securities and Exchange Commission (the “Commission”), complied as to form in all material respects with the requirements of the Exchange Act, and none
of such documents, in each case when filed with the Commission contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Time of Sale Information or the Offering Memorandum, when such documents are filed with the Commission, will conform in
all material respects to the requirements of the Exchange Act and shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading. 
 (d)        Financial
Statements. The financial statements and the related notes thereto included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum comply in all material respects with the applicable requirements of the
Securities Act and the Exchange Act, as applicable, and present fairly the consolidated financial position, results of operations and cash flows of the Company and its consolidated subsidiaries, as of the dates and for the periods indicated, and
said financial statements have been prepared in conformity with generally accepted 

  
 6 

 accounting principles in the United States (“GAAP”) applied on a consistent basis throughout the
periods covered thereby, and any supporting schedules included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum present fairly the information required to be stated therein; and the other financial
information included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum has been derived from the accounting records of the Company and its consolidated subsidiaries, as applicable, and presents fairly
the information shown thereby. 
 (e)        No Material Adverse Change. Since the respective
dates as of which information is given in each of the Time of Sale Information and the Offering Memorandum (exclusive of any amendment or supplement thereto), except as disclosed therein, there has not been (A) any material change in the issued
capital stock, long-term debt, warrants or options except pursuant to the terms of the instruments governing the same or pursuant to the exercise of such options or warrants, or the issuance of certain options of the Company or any of the
Subsidiaries (as defined herein), or (B) any material adverse change, or any development involving a prospective material adverse change, in or affecting the general affairs, the management, business, financial position, stockholders’
equity or results of operations of the Company and the Subsidiaries, taken as a whole (a “Material Adverse Change”). Since the respective dates as of which information is given in each of the Time of Sale Information and the
Offering Memorandum (exclusive of any amendment or supplement thereto), except as disclosed therein, (i) there have been no transactions entered into by the Company or by any of the Subsidiaries, including those entered into in the ordinary
course of business, that are material to the Company and the Subsidiaries taken as a whole; and (ii) there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock, except for
quarterly dividends in accordance with the past practices of the Company. 

(f)        Organization and Good Standing of the Company and the Subsidiaries. The Company and
each Subsidiary has been duly incorporated or organized under the laws of its jurisdiction of incorporation or organization; is validly existing and in good standing under the laws of its jurisdiction of incorporation or organization; is duly
qualified to do business and is in good standing in each other jurisdiction in which it owns or leases property, or conducts any business, so as to require such qualification, except where the failure to be so qualified or in good standing or have
such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders’ equity, results of operations or prospects of the Company and the
Subsidiaries taken as a whole or on the performance by the Company or any of the Subsidiaries of its obligations under the Transaction Documents (as defined below) to which it is a party (a “Material Adverse Effect”). 

(g)        Capitalization. The Company has the capitalization set forth in each of the Time of
Sale Information and the Offering Memorandum under the heading “Capitalization”; all the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar rights; and except as described in or expressly 

  
 7 

 contemplated by the Time of Sale Information and the Offering Memorandum (including all outstanding equity awards
granted under the Company’s employee benefit plans), there are no outstanding rights (including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments convertible into or
exchangeable for, any shares of capital stock or other equity interests in the Company or any of the Subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock or
other equity interests in the Company or any such Subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in all material respects to the description thereof
contained in the Time of Sale Information and the Offering Memorandum; and except as described in the Time of Sale Information and the Offering Memorandum, the Company owns, directly or indirectly, free and clear of any mortgage, pledge, security
interest, lien, claim or other encumbrance or restriction on transferability or voting (other than as may be imposed by the Securities Act and the various state securities laws), all of the outstanding capital stock or other equity interests of each
of its Significant Subsidiaries. All of the outstanding capital stock or other equity interests of each Subsidiary of the Company has been duly authorized and validly issued and is fully paid and
non-assessable. 
 (h)        Due Authorization. The
Company and the Guarantor have the requisite power and authority to execute and deliver (to the extent it is a party hereto or thereto) this Agreement, the Indenture, the Securities, the Guarantee, the Recovery Zone Facility Bonds Amendment and the
Term Loan Credit Agreement (collectively, the “Transaction Documents”) and to perform their respective obligations hereunder and thereunder; and all action required to be taken for the due and proper authorization, execution and
delivery by it of each of the Transaction Documents and the consummation by it of the transactions contemplated hereby and thereby has been duly and validly taken. 

(i)        The Indenture. The Indenture has been duly authorized by the Company and the
Guarantor and on the Closing Date when duly executed and delivered in accordance with its terms by each of the parties thereto, will constitute a valid and legally binding agreement of the Company, and the Guarantor enforceable against the Company
and the Guarantor in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally or by equitable principles relating to enforceability
(collectively, the “Enforceability Exceptions”). 
 (j)        Purchase
Agreement. This Agreement has been duly authorized, executed and delivered by the Company and the Guarantor. 

(k)        The Securities and the Guarantee. The Securities to be issued and sold by the
Company hereunder have been duly authorized by the Company for issuance and, when duly executed, authenticated, issued and delivered as provided in the Indenture and paid for by the Initial Purchasers in accordance with the terms hereof, will be
duly and validly issued and will constitute valid and legally binding obligations of the Company enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the
Indenture; and the Guarantee has been duly authorized by the Guarantor and, when the Securities have been 

  
 8 

 duly executed, issued and delivered as provided in the Indenture, will constitute a valid and legally binding
obligation of the Guarantor, enforceable against the Guarantor in accordance with its terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. 

(l)        Enforceability of other Transaction Documents. The Recovery Zone Facility Bonds
Amendment constitutes and, on or prior to the Closing Date, the Term Loan Credit Agreement will constitute, valid and legally binding agreements of the Company and its Subsidiaries party thereto enforceable against the Company and such Subsidiaries
in accordance with their terms, except as enforceability may be limited by the Enforceability Exceptions. 

(m)        Descriptions of the Transaction Documents. Each Transaction Document conforms in all
material respects to the description thereof contained in each of the Time of Sale Information and the Offering Memorandum. 

(n)        No Violation or Default. None of the Company or any of the Subsidiaries is
(i) in violation of its Certificate of Incorporation, By-Laws or similar organizational documents (and, in the case of the Company’s Subsidiaries that are not Significant Subsidiaries only, in any
material respect); (ii) in breach or violation of any of the terms or provisions of, or with the giving of notice or lapse of time, or both, would be in default under, any contract, indenture, mortgage, deed of trust, loan agreement, note, lease,
partnership agreement or other agreement or instrument to which the Company or any Subsidiary is a party or by which any of them may be bound or to which any of their properties or assets may be subject; or (iii) in violation of any applicable
law or statute, rule or regulation or any judgment, order or decree of any government, governmental instrumentality, agency, body or court, domestic or foreign, having jurisdiction over the Company or any such Subsidiary or any of their respective
properties or assets, except, in the case of clauses (ii) and (iii) above, for any such breach, violation or default that would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(o)        No Conflicts. The execution and delivery by each of the Company and the Guarantor
and the performance by each of the Company and the Guarantor of all of the provisions of, and its obligations under, the Transaction Documents to which it is a party and the consummation by each of the Company and the Guarantor of the transactions
herein and therein contemplated and as set forth in the Time of Sale Information and the Offering Memorandum will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or of any Subsidiary pursuant to, any indenture, mortgage, deed of trust, loan agreement, note, lease, partnership agreement or
other agreement or instrument to which the Company or any such Subsidiary is a party or by which any of them is bound or to which any of their respective properties or assets may be subject; (ii) result in any violation of the provisions of the
respective charter, by-laws or similar organizational documents of the Company or any of the Subsidiaries; or (iii) result in the violation of any applicable law or statute, rule or regulation (other
than the securities or Blue Sky laws of the various states of the United States of America) or any judgment, order or 

  
 9 

 decree of any government, governmental instrumentality, agency, body or court, domestic or foreign, having
jurisdiction over the Company or any such Subsidiary or any of their respective properties or assets, except, in the case of clauses (i) and (iii) above, for any such violation, conflict, breach or default that would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect. 
 (p)        No Consents
Required. No authorization, approval, consent, order, registration, qualification or license of, or filing with, any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the
Company or the Guarantor of any of the Transaction Documents to which it is party, the issuance and sale of the Securities or the Guarantee, as applicable, and the consummation of the transactions contemplated by the Time of Sale Information and the
Offering Memorandum, other than such authorizations, approvals, consents, orders and registrations or qualifications as may be required under applicable state securities or Blue Sky laws in connection with the purchase and distribution of the
Securities by the Initial Purchasers, except where the failure to obtain such authorization, approval, consent, order, registration, qualification or license or to make any such filing would not reasonably be expected, individually or in the
aggregate, to have a material adverse effect on the consummation of the transactions contemplated by, or the fulfillment of the terms of, this Agreement or the Time of Sale Information and the Offering Memorandum. 

(q)        Legal Proceedings. Except as described in each of the Time of Sale Information and
the Offering Memorandum, there is no action, suit or proceeding before or by any government, governmental instrumentality, agency, body or court, domestic or foreign, now pending or, to the best knowledge of the Company and the Guarantor, threatened
against or affecting the Company or any of the Subsidiaries that could reasonably be expected to have a Material Adverse Effect or that could have a material adverse effect on the consummation of the Transactions or the other transactions
contemplated by, or the fulfillment of the terms of, this Agreement or the Time of Sale Information and the Offering Memorandum; there is no action, suit or proceeding before or by any government, governmental instrumentality, agency, body or court
now pending or, to the best knowledge of the Company and the Guarantor, threatened against or affecting the Company or any of the Subsidiaries that would be required to be described pursuant to Item 103 of Regulation
S-K under the Securities Act if the issuance of the Notes was being registered under the Securities Act, but is not described in the Time of Sale Information and the Offering Memorandum. 

(r)        Independent Accountants. KPMG LLP, which has certified certain financial statements
of the Company and the Subsidiaries, is an independent registered public accounting firm with respect to the Company and the Subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting
Oversight Board (United States) (the “PCAOB”) and as required by the Securities Act. 

(s)        Title to Real and Personal Property. The Company and the Subsidiaries have
good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them, in each case, that is material to the business 

  
 10 

 of the Company and the Subsidiaries, in each case free and clear of all liens, encumbrances and defects except
such as are described in the Time of Sale Information and the Offering Memorandum or to the extent the failure to have such title, or the existence of such liens, encumbrances or defects, would not reasonably be expected to have a Material Adverse
Effect. 
 (t)        Title to Intellectual Property. The Company and the Subsidiaries
own, possess or can acquire on reasonable terms, adequate trademarks, trade names and other rights to inventions, know how, patents, copyrights, confidential information and other intellectual property (collectively, “intellectual property
rights”) necessary to conduct the business now operated by them, or presently employed by them, and have not received any notice of infringement of or conflict with asserted rights of others with respect to any intellectual property rights
that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

(u)        No Undisclosed Relationships.    No relationship, direct or
indirect, exists between or among the Company or any of the Subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of the Subsidiaries, on the other, that would be
required by the Securities Act to be described in a registration statement on Form S-1 to be filed with the Commission and that is not so described in each of the Time of Sale Information and the Offering
Memorandum. 
 (v)        Investment Company Act. Neither the Company nor the Guarantor is,
and after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as described in the Time of Sale Information and the Offering Memorandum neither will be, an “investment company” or an entity
“controlled” by an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Investment Company
Act”). 
 (w)        Taxes. The Company and the Subsidiaries have satisfied all
United States federal, state and local taxes and foreign taxes and filed all tax returns required to be paid or filed through the date hereof; and except as otherwise disclosed in the Time of Sale Information and the Offering Memorandum, there is no
material tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of the Subsidiaries or any of their respective properties or assets. 

(x)        Licenses and Permits. The Company and each of the Subsidiaries have all licenses,
franchises, permits, authorizations, approvals and orders and other concessions of and from all governmental or regulatory authorities that are necessary to own or lease their properties and conduct their businesses as described in the Time of Sale
Information and the Offering Memorandum, except where the failure to have such licenses, franchises, permits, authorizations, approvals and orders would not reasonably be expected, individually or in the aggregate, have a Material Adverse Effect.

  
 11 

 (y)        No Labor Disputes. No labor dispute
with the employees of the Company or any of the Subsidiaries exists or, to the knowledge of the Company and the Guarantor, is imminent that could have a Material Adverse Effect. 

(z)        Compliance with Environmental Laws. Except as described in the Time of Sale
Information and the Offering Memorandum, there has been no storage, generation, transportation, handling, treatment, disposal, discharge, emission or other release of any kind of toxic or other wastes or other hazardous substances by, due to or
caused by, to the best knowledge of the Company and the Guarantor, the Company or any of the Subsidiaries or any other entity (including any predecessor) for whose acts or omissions any of the Company or any of the Subsidiaries is or could
reasonably be expected to be liable, upon any of the property now or previously owned or leased by the Company or any of the Subsidiaries, or upon any other property, in violation of any statute or any ordinance, rule, regulation, order, judgment,
decree or permit, or that would, under any statute or any ordinance, rule (including rule of common law), regulation, order, judgment, decree or permit, give rise to any liability, except for any violation or liability that could not reasonably
be expected to have, individually or in the aggregate with all such violations and liabilities, a Material Adverse Effect; and except as described in the Time of Sale Information and the Offering Memorandum, there has been no disposal, discharge,
emission or other release of any kind onto such property or into the environment surrounding such property of any toxic or other wastes or other hazardous substances with respect to which the Company or the Guarantor has knowledge, except for any
such disposal, discharge, emission or other release of any kind that could not reasonably be expected to have, individually or in the aggregate with all such discharges and other releases, a Material Adverse Effect. 

(aa)        Compliance with ERISA. Except as set forth in the Time of Sale Information and the
Offering Memorandum or as would not reasonably be expected to have a Material Adverse Effect, (i) each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended
(“ERISA”), for which the Company or any member of its “Controlled Group” (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14) of
ERISA or any entity that would be regarded as a single employer with the Company under Section 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended (the “Code”)) would have any liability (each, a
“Plan”) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations including, but not limited to, ERISA and the Code; (ii) no prohibited transaction, within
the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii) neither the Company nor any member of
the Controlled Group has failed to make any required contribution to any Plan that is subject to Title IV of ERISA when due under Section 412 and 430 of the Code and Sections 303 and 304 of ERISA, the conditions for imposition of a lien under
Section 430(k) of the Code and Section 303(k) of ERISA have not been met with respect to any Plan, and no determination that a Plan (that is a “multiemployer plan” within the meaning of Section 4001(a)(3) of ERISA) is in
“at risk” status (within the meaning of Section 430(i) of the Code and Section 303(i) of ERISA) has been made; (iv) no “reportable event” (within the meaning of Section 4043(c) of ERISA or the regulations

  
 12 

 thereunder for which the reporting requirements have not been waived) has occurred or is reasonably expected to
occur (for which the reporting requirements are not reasonably expected to be waived); and (v) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA
(other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default) in respect of a Plan (including a “multiemployer plan”, within the meaning of
Section 4001(a)(3) of ERISA). 
 (bb)        Disclosure Controls. The Company maintains
and will maintain “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) designed to ensure that information required to be disclosed by the Company in the reports
that it files or submits under the Exchange Act is recorded, processed, summarized and reported in accordance with the Exchange Act. The Company has carried out and will carry out evaluations, under the supervision and with the participation of the
Company’s management, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures in accordance with Rule 13a-15 of the Exchange Act. 

(cc)        Accounting Controls. Except as disclosed in the Time of Sale Information and the
Offering Memorandum, the Company maintains a system of internal controls, including, but not limited to, internal controls over accounting matters and financial reporting, an internal audit function, and legal and regulatory compliance controls
(collectively, “Internal Controls”) that comply with (a) the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”), (b) the Securities Act, (c) the Exchange Act, (d) the auditing principles, rules, standards
and practices applicable to auditors of “issuers” (as defined in Sarbanes-Oxley) promulgated or approved by the PCAOB and (e) as applicable, the rules of the New York Stock Exchange (the “Exchange” and, such rules,
the “Exchange Rules”) (clauses (a) through (e), collectively, the “Securities Laws”) and are sufficient to provide reasonable assurances that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets, (iii) access to assets is
permitted only in accordance with management’s general or specific authorization, (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences and (v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Time of Sale Information and the Offering Memorandum fairly presents the information called for in all material respects
and is prepared in accordance with the Commission’s rules and guidelines applicable thereto. The Internal Controls are, and upon consummation of the offering of the Securities will be, overseen by the Audit Committee (the “Audit
Committee”) of the Board of Directors of the Company (the “Board”) in accordance with the Exchange Rules. Except as disclosed in the Time of Sale Information and the Offering Memorandum, the Company has not publicly
disclosed or reported to the Audit Committee or the Board, and has no plans or current intentions to publicly disclose or report to the Audit Committee or the Board, any material weakness, material change in Internal Controls or fraud involving
management or other employees who have a significant role in Internal Controls (each, an “Internal Control Event”), any material 

  
 13 

 violation of, or material failure to comply with, the Securities Laws or any other matter that, if determined
adversely, would have a Material Adverse Effect. 
 (dd)        Absence of Accounting Issues.
Except as set forth in the Time of Sale Information and the Offering Memorandum, the Audit Committee is not reviewing or investigating, and neither the Company’s independent auditors nor its internal auditors have recommended that the Audit
Committee review or investigate, (i) adding to, deleting, changing the application of or changing the disclosure of the Company with respect to, any of the material accounting policies of the Company, (ii) any matter that could result in a
restatement of the financial statements of the Company for any annual or interim period during the current fiscal year or the prior three fiscal years or (iii) any Internal Control Event. 

(ee)        eXtensible Business Reporting Language. The interactive data in eXtensible Business
Reporting Language included or incorporated by reference in the Time of Sale Information and the Offering Memorandum fairly presents the information called for in all material respects and has been prepared in accordance with the Commission’s
rules and guidelines applicable thereto. 
 (ff)        Insurance. The Company and its
Significant Subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as are adequate to
protect the Company and its Significant Subsidiaries and their respective businesses; and neither the Company nor any of its Significant Subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or
other material expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. 

(gg)        (i) No Unlawful Payments. Neither the Company nor any of the Subsidiaries
nor any director, officer or employee of the Company or any of the Subsidiaries nor, to the knowledge of the Company and the Guarantor, any agent, affiliate or other person associated with or acting on behalf of the Company or any of the
Subsidiaries has (a) used any funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (b) made or taken an act in furtherance of an offer, promise or authorization of any direct or
indirect unlawful payment or benefit to any foreign or domestic government or regulatory official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official
capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (c) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any
applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable
anti-bribery or anti-corruption laws; or (d) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other 

  
 14 

 unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other
unlawful or improper payment or benefit. The Company and the Subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable
anti-bribery and anti-corruption laws. 
 (ii) Compliance with Anti-Money Laundering Laws. The operations of
the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the applicable money laundering statutes of all jurisdictions where the Company or any of the Subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or
enforced by any governmental or regulatory agency (collectively, the “Anti-Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or any arbitrator
involving the Company or any of the Subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company and the Guarantor, threatened. 

(iii) No Conflicts with Sanctions Laws. Neither the Company nor any of the Subsidiaries, directors, officers or
employees, nor, to the knowledge of the Company and the Guarantor, any agent, affiliate or other person associated with or acting on behalf of the Company or any of the Subsidiaries is currently the subject or the target of any sanctions
administered or enforced by the U.S. Government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State and including, without limitation,
the designation as a “specially designated national” or “blocked person”), the United Nations Security Council (“UNSC”), the European Union, Her Majesty’s Treasury (“HMT”), or other relevant
sanctions authority (collectively, “Sanctions”), nor is the Company or any of the Subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation,
Crimea, Cuba, Iran, North Korea, Sudan and Syria (each, a “Sanctioned Country”); and the Company and the Guarantor will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (a) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject
or the target of Sanctions, (b) to fund or facilitate any activities of or business in any Sanctioned Country or (c) in any other manner that will result in a violation by any person (including any person participating in the transaction,
whether as Initial Purchaser, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and the Subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not engage in, any dealings or
transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. 

  
 15 

 (hh)        Solvency. On and immediately after the
Closing Date, the Company and the Guarantor (after giving effect to the issuance and sale of the Securities, the issuance of the Guarantee and the other Transactions as described in each of the Time of Sale Information and the Offering Memorandum)
will each be Solvent. As used in this paragraph, “Solvent” means, with respect to a particular date and entity, that on such date (i) the fair value (and present fair saleable value) of the assets of such entity is not less
than the total amount required to pay the probable liability of such entity on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii) such entity is able to realize upon its assets
and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business; (iii) assuming consummation of the issuance and sale of the Securities and the issuance of the
Guarantee as contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, such entity does not have, intend to incur or believe that it will incur debts or liabilities beyond its ability to pay such debts and liabilities
as they mature; (iv) such entity is not engaged in any business or transaction for which its property would constitute unreasonably small capital; and (v) such entity is not a defendant in any civil action that would result in a judgment
that such entity is or would become unable to satisfy. 
 (ii)        No Broker’s Fees.
Except as disclosed in the Time of Sale Information and the Offering Memorandum, there are no contracts, agreements or understandings between the Company or the Guarantor and any person that would give rise to a valid claim against the Company, the
Guarantor or any Initial Purchaser for a brokerage commission, finder’s fee or other like payment in connection with this offering. 

(jj)        Rule 144A Eligibility. On the Closing Date, the Securities will not be of the same
class as securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation system; and each of the Preliminary Offering Memorandum and the Offering Memorandum, as
of its respective date, contains or will contain all the information that, if requested by a prospective purchaser of the Securities, would be required to be provided to such prospective purchaser pursuant to Rule 144A(d)(4) under the Securities
Act. 
 (kk)        No Integration. Neither the Company nor any of its affiliates (as defined
in Rule 501(b) of Regulation D) or any person acting on their behalf has, directly or indirectly, solicited any offer to buy or offered to sell, or will, directly or indirectly, solicit any offer to buy or offer to sell, any security that is or
would be integrated with the sale of the Securities in a manner that would require registration of the Securities under the Securities Act. 

(ll)        No General Solicitation or Directed Selling Efforts. None of the Company or any of
its affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no representation is made) has (i) solicited offers for, or offered or sold, the Securities by means of any form of general
solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engaged in any directed selling efforts
within the meaning of Regulation S under the 

  
 16 

 Securities Act (“Regulation S”), and all such persons have complied with the offering
restrictions requirement of Regulation S. 
 (mm)        Securities Law Exemptions. Assuming
the accuracy of the representations and warranties of the Initial Purchasers contained in Section 1(b) (including Annex C) and their compliance with their agreements set forth therein, it is not necessary, in connection with the issuance and
sale of the Securities to the Initial Purchasers and the offer, resale and delivery of the Securities by the Initial Purchasers in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, to register the
Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act. 

(nn)        No Stabilization. Except as the Initial Purchasers may stabilize as described in
the Offering Memorandum, neither the Company nor the Guarantor has taken, directly or indirectly, any action that is designed to or that has constituted or that would reasonably be expected to cause or result in the stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of the Securities. 

(oo)        Margin Rules. Neither the issuance, sale and delivery of the Securities nor the
application of the proceeds thereof by the Company as described in the Time of Sale Information and the Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such
Board of Governors. 
 (pp)        Statistical and Market Data. Any third-party statistical
and market-related data included or incorporated by reference in the Time of Sale Information and the Offering Memorandum is based on or derived from sources that the Company and the Guarantor believe to be reliable and accurate. 

(qq)        Sarbanes-Oxley Act. The Company is in compliance in all material respects with the
applicable provisions of Sarbanes-Oxley that are effective and the rules and regulations of the Commission that have been adopted and are effective thereunder. 

4.        Further Agreements of the Company and the Guarantor. The Company and the Guarantor
jointly and severally covenant and agree with each Initial Purchaser that: 
 (a)        Delivery
of Copies. The Company will deliver, without charge, to the Initial Purchasers as many copies of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including all
amendments and supplements thereto) as the Representative may reasonably request. 

(b)        Offering Memorandum, Amendments or Supplements. Before finalizing the Offering
Memorandum or making or distributing any amendment or supplement to any of the Time of Sale Information or the Offering Memorandum or filing with the Commission any document that will be incorporated by reference therein, the Company will furnish to
the Representative and counsel for the Initial Purchasers a copy of the proposed Offering Memorandum or such amendment or supplement or document to be 

  
 17 

 incorporated by reference therein for review, and will not distribute any such proposed Offering Memorandum,
amendment or supplement or file any such document with the Commission to which the Representative reasonably objects. 

(c)        Additional Written Communications. Before making, preparing, using, authorizing,
approving or referring to any Issuer Written Communication, the Company will furnish to the Representative and counsel for the Initial Purchasers a copy of such written communication for review and will not make, prepare, use, authorize, approve or
refer to any such written communication to which the Representative reasonably objects. 

(d)        Notice to the Representative. The Company will advise the Representative promptly,
and confirm such advice in writing, (i) of the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering
Memorandum or the initiation or threatening of any proceeding for that purpose; (ii) of the occurrence of any event at any time prior to the completion of the initial offering of the Securities as a result of which any of the Time of Sale
Information, any Issuer Written Communication or the Offering Memorandum as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances existing when such Time of Sale Information, Issuer Written Communication or the Offering Memorandum is delivered to a purchaser, not misleading; and (iii) of the receipt by the Company of any notice with respect to
any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any
such order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum or suspending any such qualification of the Securities and, if any such order is issued, will obtain as
soon as possible the withdrawal thereof. 
 (e)        Time of Sale Information. If at any
time prior to the Closing Date (i) any event or development shall occur or condition shall exist as a result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to
comply with law, the Company will immediately notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Time of Sale Information (or
any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in any of the Time of Sale Information as so amended or supplemented (including such documents to be incorporated by
reference therein) will not, in the light of the circumstances under which they were made, be misleading or so that any of the Time of Sale Information will comply with law. 

(f)        Ongoing Compliance. If at any time prior to the completion of the initial offering
of the Securities (i) any event or development shall occur or condition shall exist as a result of which the Offering Memorandum as then amended or supplemented would 

  
 18 

 include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Offering Memorandum to comply with law, the Company will
promptly notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Offering Memorandum (or any document to be filed with the
Commission and incorporated by reference therein) as may be necessary so that the statements in the Offering Memorandum as so amended or supplemented (including such documents to be incorporated by reference therein) will not, in the light of the
circumstances existing when the Offering Memorandum is delivered to a purchaser, be misleading and so that the Offering Memorandum will comply with law. 

(g)        Blue Sky Compliance. The Company will qualify the Securities for offer and sale
under the securities or Blue Sky laws of such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required for the offering and resale of the Securities; provided that
neither the Company nor the Guarantor shall be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any
general consent to service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject. 

(h)        Clear Market. For a period of 90 days after the date of the Offering Memorandum,
none of the Company, the Guarantor or any of the Subsidiaries will, without the prior written consent of the Representative, offer, pledge, sell, contract to sell or otherwise dispose of, directly or indirectly, any debt securities issued or
guaranteed by the Company or the Guarantor and having a tenor of more than one year. 

(i)        Use of Proceeds. The Company will apply the net proceeds from the sale of the
Securities as described in each of the Time of Sale Information and the Offering Memorandum under the heading “Use of Proceeds” and, except as disclosed in the Time of Sale Information and the Offering Memorandum, the Company does not
intend to use any of the proceeds from the sale of the Securities hereunder to repay any outstanding debt owed to any affiliate of any Initial Purchaser. 

(j)        Supplying Information. While the Securities remain outstanding and are
“restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Company will, during any period in which the Company is not subject to and in compliance with Section 13 or 15(d) of the Exchange Act, furnish
to holders of the Securities and prospective purchasers of the Securities designated by such holders, upon the request of such holders or such prospective purchasers, the information required to be delivered pursuant to Rule 144A(d)(4) under the
Securities Act. 
 (k)        DTC.    The Company will assist the Initial
Purchasers in arranging for the Securities to be eligible for clearance and settlement through DTC. 

(l)        No Resales by the Company. During the period of one year after the Closing Date, the
Company will not, and will not permit any of its affiliates (as defined in 

  
 19 

 Rule 144 under the Securities Act) to, resell any of the Securities that have been acquired by any of them,
except for Securities purchased by the Company or any of its affiliates and resold in a transaction registered under the Securities Act. 

(m)        No Integration. Neither the Company nor any of its affiliates (as defined in Rule
501(b) of Regulation D) or any person acting on their behalf has, directly or indirectly, solicited any offer to buy or offered to sell, or will, directly or indirectly, solicit any offer to buy or offer to sell, any security that is or would be
integrated with the sale of the Securities in a manner that would require registration of the Securities under the Securities Act. 

(n)        No General Solicitation or Directed Selling Efforts. None of the Company or any of
its affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no covenant is given) will (i) solicit offers for, or offer or sell, the Securities by means of any form of general solicitation or
general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engage in any directed selling efforts within the
meaning of Regulation S, and all such persons will comply with the offering restrictions requirement of Regulation S. 

(o)        No Stabilization. Except as the Initial Purchasers may stabilize as described in the
Offering Memorandum, the Company and the Guarantor will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, stabilization or manipulation of the price of any
securities of the Company to facilitate the sale or resale of the Securities. 

(p)        Reports. So long as the Securities are outstanding, the Company will furnish to the
Representative, as soon as they are available, copies of all reports or other communications (financial or other) furnished to holders of the Securities, and copies of any reports and financial statements furnished to or filed with the Commission or
any national securities exchange or automatic quotation system; provided that the Company will be deemed to have furnished such reports and financial statements to the Representative to the extent they are filed on the Commission’s
Electronic Data Gathering, Analysis, and Retrieval system. 
 5.        Certain Agreements of the
Initial Purchasers. Each Initial Purchaser hereby represents and agrees that it has not used and will not use, authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an offer to sell or
the solicitation of an offer to buy the Securities other than (i) the Preliminary Offering Memorandum and the Offering Memorandum, (ii) any written communication that contains either (a) no “issuer information” (as defined
in Rule 433(h)(2) under the Securities Act) or (b) “issuer information” that was included (including through incorporation by reference) in the Time of Sale Information or the Offering Memorandum, (iii) any written communication
listed on Annex A or prepared pursuant to Section 4(c) above (including any electronic road show), (iv) any written communication prepared by such Initial Purchaser and approved by the Company in advance in writing or (v) any written
communication relating to or that contains the terms of the Securities and/or other information that was included (including through 

  
 20 

 incorporation by reference) in the Time of Sale Information or the Offering Memorandum. 

6.        Conditions of Initial Purchasers’ Obligations. The several (and not joint)
obligation of each Initial Purchaser to purchase Securities on the Closing Date as provided herein is subject to the performance by the Company and the Guarantor of their respective covenants and other obligations hereunder and to the following
additional conditions: 
 (a)        Representations and Warranties. The representations and
warranties of the Company and the Guarantor contained herein shall be true and correct on the date hereof and on and as of the Closing Date and the statements of the Company, the Guarantor and their respective officers made in any certificates
delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date. 

(b)        No Downgrade. Except as otherwise disclosed in the Time of Sale Information and the
Offering Memorandum, subsequent to the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement, (i) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or
preferred stock issued or guaranteed by the Company or any of the Subsidiaries by any “nationally recognized statistical rating organization,” as such term is defined in Section 3(a)(62) of the Exchange Act, and (ii) no such
organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock issued or guaranteed by the Company or
any of the Subsidiaries (other than an announcement with positive implications of a possible upgrading). 

(c)        No Material Adverse Change. No event or condition of a type described in
Section 3(e) hereof shall have occurred or shall exist, which event or condition is not described in each of the Time of Sale Information (excluding any amendment or supplement thereto) and the Offering Memorandum (excluding any amendment or
supplement thereto) and the effect of which in the judgment of the Representative makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the Closing Date on the terms and in the manner contemplated
by this Agreement, the Time of Sale Information and the Offering Memorandum. 

(d)        Officers’ Certificate. The Representative shall have received on and as of the
Closing Date a certificate of each of (i) the chief financial officer or chief accounting officer of the Company and one additional senior executive officer of the Company who is satisfactory to the Representative and (ii) the chief
financial officer or chief accounting officer of the Guarantor and one additional senior executive officer of the Guarantor who is satisfactory to the Representative, in each case, (x) confirming that such officers have carefully reviewed the
Time of Sale Information and the Offering Memorandum and, to the knowledge of such officers, the representations set forth in Sections 3(a) and 3(b) hereof are true and correct, (y) confirming that the other representations and warranties of
the Company and the Guarantor in this Agreement are true and correct and that the Company and the Guarantor have complied in all material respects with all agreements 

  
 21 

 and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date
and (z) to the effect set forth in paragraphs (b) and (c) above. 
 (e)        Comfort
Letters. On the date of this Agreement and on the Closing Date KPMG LLP shall have furnished to the Representative, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Initial Purchasers,
in form and substance reasonably satisfactory to the Representative, containing statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and
certain financial information of the Company and the Subsidiaries contained or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum; provided that the letter delivered on the Closing Date shall use a “cut-off” date that is no more than three business days prior to such Closing Date. 

(f)        Opinion and 10b-5 Statement of Counsel for the
Company. Kirkland & Ellis LLP, counsel for the Company, shall have furnished to the Representative, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing
Date, and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative. 

(g)        Opinion of General Counsel for the Company. Curt A. Kramer, as General Counsel for
the Company, shall have furnished to the Representative, at the request of the Company, his written opinion and 10b-5 statement, dated the Closing Date and addressed to the Initial Purchasers, in form and
substance reasonably satisfactory to the Representative. 
 (h)        Opinion and 10b-5 Statement of Counsel for the Initial Purchasers. The Representative shall have received on and as of the Closing Date an opinion and 10b-5 statement, addressed to
the Initial Purchasers, of Cravath, Swaine & Moore LLP, counsel for the Initial Purchasers, with respect to such matters as the Representative may reasonably request, and such counsel shall have received such documents and information as
they may reasonably request to enable them to pass upon such matters. 
 (i)        No Legal
Impediment to Issuance. No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing
Date, prevent the issuance or sale of the Securities or the issuance of the Guarantee; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the
Securities or the issuance of the Guarantee. 
 (j)        Good Standing. The Representative
shall have received on and as of the Closing Date satisfactory evidence of the good standing of the Company and the Subsidiaries in their respective jurisdictions of organization and their good standing as foreign entities in such other
jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. 

  
 22 

 (k)        DTC. The Securities shall be eligible
for clearance and settlement through DTC. 
 (l)        Indenture and the Securities.
(i) The Indenture shall have been duly executed and delivered by a duly authorized officer of the Company, the Guarantor and the Trustee, (ii) the Securities shall have been duly executed and delivered by a duly authorized officer of the
Company and duly authenticated by the Trustee and (iii) the Guarantee shall have been duly executed and delivered by a duly authorized officer of the Guarantor. 

(m)        Additional Documents. On or prior to the Closing Date, the Company and the Guarantor
shall have furnished to the Representative such further certificates and documents as the Representative may reasonably request. 
 All
opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Initial
Purchasers. 
 7.        Indemnification and Contribution.  

(a)        Indemnification of the Initial Purchasers. The Company and the Guarantor jointly and
severally agree to indemnify and hold harmless each Initial Purchaser, its affiliates, directors and officers and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees
and expenses are incurred), joint or several, that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Preliminary Offering Memorandum, any of the other Time of Sale Information, any
Issuer Written Communication or the Offering Memorandum (or any amendment or supplement thereto) or any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in
reliance upon and in conformity with any information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use therein, it being understood and agreed that the only
such information furnished by any Initial Purchaser consists of the information described as such in subsection (b) below. 

(b)        Indemnification of the Company and the Guarantor. Each Initial Purchaser agrees,
severally and not jointly, to indemnify and hold harmless the Company, the Guarantor, their respective directors and officers and each person, if any, who controls the Company or the Guarantor within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities 

  
 23 

 that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission
made in reliance upon and in conformity with any information relating to such Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, any of
the other Time of Sale Information, any Issuer Written Communication or the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed that the only such information furnished by any Initial Purchaser consists of
the following information in the Preliminary Offering Memorandum and the Offering Memorandum: (i) the fourth paragraph, (ii) the fourth and fifth sentences of the eighth paragraph and (iii) the eleventh paragraph, each under the
caption “Plan of distribution” section therein. 
 (c)        Notice and
Procedures. If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph
(a) or (b) above, such person (the “Indemnified Person”) shall promptly notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure
to notify the Indemnifying Person shall not relieve it from any liability that it may have under paragraph (a) or (b) above except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses)
by such failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above. If any
such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not,
without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such
proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall
have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that
there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying
Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in
connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses
shall be paid or reimbursed as they are incurred. Any such separate firm for any Initial Purchaser, its affiliates, directors and officers and any control persons of such Initial Purchaser shall be designated in writing by J.P. Morgan Securities LLC
and any such separate firm for the Company, the Guarantor, their respective directors and officers and any control persons of the Company or the Guarantor shall be designated in writing by the Company. The Indemnifying

  
 24 

 Person shall not be liable for any settlement of any proceeding effected without its written consent, but if
settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the
foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable
for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have
reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened
proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such
Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person. 

(d)        Contribution. If the indemnification provided for in paragraphs (a) and (b)
above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person
thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company
and the Guarantor, on the one hand, and the Initial Purchasers on the other, from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company and the Guarantor, on the one hand, and the Initial Purchasers, on the other, in connection with the statements or omissions that
resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Guarantor, on the one hand, and the Initial Purchasers, on the other, shall be
deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company and the Guarantor from the sale of the Securities and the total discounts and commissions received by the Initial Purchasers, in
connection therewith, as provided in this Agreement, bear to the aggregate offering price of the Securities. The relative fault of the Company and the Guarantor, on the one hand, and the Initial Purchasers, on the other, shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Guarantor or by the Initial
Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

(e)        Limitation on Liability. The Company, the Guarantor and the Initial Purchasers agree
that it would not be just and equitable if contribution pursuant to 

  
 25 

 paragraph (d) above were determined by pro rata allocation (even if the Initial Purchasers
were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of
the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such
action or claim. Notwithstanding the provisions of paragraphs (d) and (e), in no event shall an Initial Purchaser be required to contribute any amount in excess of the amount by which the total discounts and commissions received by such Initial
Purchaser with respect to the offering of the Securities exceeds the amount of any damages that such Initial Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’
obligations to contribute pursuant to paragraphs (d) and (e) are several in proportion to their respective purchase obligations hereunder and not joint. 

(f)        Non-Exclusive Remedies. The remedies
provided for in this Section 7 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Person at law or in equity. 

8.        Termination. This Agreement may be terminated in the absolute discretion of the
Representative, by notice to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date (i) trading generally shall have been suspended or materially limited on or by any of the Exchange, the Nasdaq Stock
Market, the Chicago Board Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of Trade; (ii) trading of any securities issued or guaranteed by the Company or the Guarantor shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities or a material
disruption in commercial banking or securities settlement or clearance services in the United States; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis,
either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the Closing Date on the
terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum. 

9.        Defaulting Initial Purchaser. 

(a)        If, on the Closing Date, any Initial Purchaser defaults on its obligation to purchase the
Securities that it has agreed to purchase hereunder on such date (the “Defaulting Initial Purchaser”), the non-defaulting Initial Purchasers may in their discretion arrange for the purchase of
such Securities by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Initial Purchaser, the non-defaulting Initial Purchasers
do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of 

  
 26 

 36 hours within which to procure other persons satisfactory to the
non-defaulting Initial Purchasers to purchase such Securities on such terms. If other persons become obligated or agree to purchase the Securities of a defaulting Initial Purchaser, either the non-defaulting Initial Purchasers or the Company may postpone the Closing Date for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the
Initial Purchasers may be necessary in the Time of Sale Information, the Offering Memorandum or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Time of Sale Information or the
Offering Memorandum that effects any such changes. As used in this Agreement, the term “Initial Purchaser” includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that,
pursuant to this Section 9, purchases Securities that a defaulting Initial Purchaser agreed but failed to purchase. 

(b)        If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Initial Purchaser or Initial Purchasers by the non-defaulting Initial Purchasers and the Company as provided in paragraph (a) above, the aggregate principal amount of Securities that remain
unpurchased on the Closing Date does not exceed one-eleventh of the aggregate principal amount of all the Securities to be purchased on such date, then the Company shall have the right to require each non-defaulting Initial Purchaser to purchase the aggregate principal amount of Securities that such Initial Purchaser agreed to purchase hereunder on such date plus such Initial Purchaser’s pro
rata share (based on the aggregate principal amount of Securities that such Initial Purchaser agreed to purchase on such date) of the Securities of such defaulting Initial Purchaser or Initial Purchasers for which such arrangements have not
been made. 
 (c)        If, after giving effect to any arrangements for the purchase of the
Securities of a defaulting Initial Purchaser or Initial Purchasers by the non-defaulting Initial Purchasers and the Company as provided in paragraph (a) above, the aggregate principal amount of Securities
that remain unpurchased on the Closing Date exceeds one-eleventh of the aggregate principal amount of Securities to be purchased on such date, or if the Company shall not exercise the right described in
paragraph (b) above, then this Agreement shall terminate without liability on the part of the non-defaulting Initial Purchasers. Any termination of this Agreement pursuant to this Section 9 shall be
without liability on the part of the Company or the Guarantor, except that the Company and the Guarantor will continue to be liable for the payment of expenses as set forth in Section 10 hereof and except that the provisions of Section 7
hereof shall not terminate and shall remain in effect. 
 (d)        Nothing contained herein shall
relieve a defaulting Initial Purchaser of any liability it may have to the Company, the Guarantor or any non-defaulting Initial Purchaser for damages caused by its default. 

10.        Payment of Expenses. 

(a)        Whether or not the transactions contemplated by this Agreement are consummated or this
Agreement is terminated, the Company and the Guarantor jointly 

  
 27 

 and severally agree to pay or cause to be paid all costs and expenses incident to the performance of their
respective obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii) the costs incident to
the preparation and printing of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including all exhibits, amendments and supplements thereto) and the distribution
thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the fees and expenses of the Company’s and the Guarantor’s counsel and independent accountants; (v) the fees and expenses
incurred in connection with the registration or qualification of the Securities under state or foreign securities or Blue Sky laws of such jurisdictions as the Representative may designate and the preparation, printing and distribution of a Blue Sky
Memorandum (including the related fees and expenses of counsel for the Initial Purchasers); (vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of the Trustee and any paying agent (including
related fees and reasonable expenses of any counsel to such parties); (viii) all expenses and application fees incurred in connection with any filing with, and clearance of the offering by, FINRA, if any, and the approval of the Securities for
book-entry transfer by DTC; (ix) all expenses incurred by the Company in connection with any “road show” presentation to potential investors (other than costs incurred by employees of the Representative); and (x) any fees charged
by investment rating agencies for rating the Securities. 
 (b)        If (i) this Agreement is
terminated pursuant to Section 8(ii), (ii) the Company for any reason fails to tender the Securities for delivery to the Initial Purchasers or (iii) the Initial Purchasers decline to purchase the Securities for any reason permitted under
this Agreement (other than upon a termination of this Agreement under Section 8), the Company and the Guarantor jointly and severally agree to reimburse the Initial Purchasers for all out-of-pocket costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Initial Purchasers in connection with this Agreement and the offering contemplated hereby;
provided that the Company and the Guarantor shall not be required to reimburse any out-of-pocket costs or expenses of a Defaulting Initial Purchaser. It is
understood, however, that, except as provided in this Section 10 and Section 7 (which shall survive any termination of this Agreement, as provided in Section 12), the Initial Purchasers will pay the fees of their counsel. 

11.        Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit
of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Initial Purchaser referred to in Section 7 hereof. Nothing in
this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Securities from any Initial Purchaser
shall be deemed to be a successor merely by reason of such purchase. 
 12.        Survival.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company, the Guarantor and the Initial Purchasers contained in this Agreement or made by or on behalf of the Company, the Guarantor or the Initial
Purchasers pursuant to this Agreement or any certificate delivered 

  
 28 

 pursuant hereto shall survive the delivery of and payment for the Securities and shall remain in full force and
effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company, the Guarantor or the Initial Purchasers. 

13.        Certain Defined Terms. For purposes of this Agreement, (a) except where
otherwise expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; (c) the term “Subsidiary” means the Company’s consolidated subsidiaries (each a Subsidiary, and collectively, the “Subsidiaries”); (d) the term “Significant
Subsidiary” has the meaning set forth in Rule 1-02 of Regulation S-X under the Exchange Act; (e) the term “Exchange Act” collectively
means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder; (f) the term “written communication” has the meaning set forth in Rule 405 under the Securities Act;
(g) the term “Recovery Zone Facility Bonds” collectively means (i) The County of Cook, Illinois Recovery Zone Facility Revenue Bonds (Navistar International Corporation Project) Series 2010, in the aggregate
principal amount of $90,000,000, which were issued under and secured by the Indenture of Trust dated as of October 1, 2010, between the County of Cook, Illinois, and Citibank N.A., as trustee (the “County of Cook Indenture”),
and the related Loan Agreement dated as of October 1, 2010, between the County of Cook, Illinois and the Company (the “County of Cook Loan Agreement”), and (ii) the Illinois Finance Authority Recovery Zone Facility Revenue
Bonds (Navistar International Corporation Project) Series 2010, in the aggregate principal amount of $135,000,000, which were issued under and secured by the Indenture of Trust dated as of October 1, 2010, between the Illinois Finance
Authority and Citibank N.A., as trustee (the “Illinois Finance Authority Indenture”), and the related Loan Agreement dated as of October 1, 2010, between the Illinois Finance Authority and the Company (the “Illinois
Finance Authority Loan Agreement”); (h) “Term Loan Credit Agreement” means that certain agreement that will govern the new term loan facility to be entered into on November 6, 2017 by and among the Company, Navistar,
Inc., the other borrowers party thereto, the guarantors from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and each lender from time to time party thereto; and (i) The term
“Recovery Zone Facility Bonds Amendment” collectively means (x) the Second Supplemental Indenture of Trust to the County of Cook Indenture, between the County of Cook, Illinois, and Citibank N.A., as trustee, and the First
Amendment to the County of Cook Loan Agreement, between the County of Cook, Illinois and the Company, each dated as of November 6, 2017 and (y) the Second Supplemental Indenture of Trust to the Illinois Finance Authority Indenture, between
the Illinois Finance Authority and Citibank N.A., as trustee, and the First Amendment to the Illinois Finance Authority Loan Agreement, between the Illinois Finance Authority and the Company, each dated as of November 6, 2017. 

14.        Miscellaneous. 

  
 29 

 (a)        Authority of the Representative. Any
action by the Initial Purchasers hereunder may be taken by the Representative on behalf of the Initial Purchasers, and any such action taken by the Representative shall be binding upon the Initial Purchasers. 

(b)        Notices. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Initial Purchasers shall be given to the Representative c/o J.P. Morgan Securities LLC, 383 Madison Avenue, New
York, New York 10179 (fax: 212-270-1063); Attention: Geoffrey Benson. Notices to the Company and the Guarantor shall be given to them at Navistar International
Corporation, 2701 Navistar Drive, Lisle, Illinois 60532 (fax: 331-332-2573); Attention: Treasurer. 

(c)        Governing Law. This Agreement and any claim, controversy or dispute arising under or
related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be performed in such state. 

(d)        Submission to Jurisdiction. The Company and the Guarantor hereby submit to the
exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in the City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company and
the Guarantor waive any objection that they may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each of the Company and the Guarantor agrees that final judgment in any such suit, action or proceeding
brought in such court shall be conclusive and binding upon the Company and the Guarantor, as applicable, and may be enforced in any court to the jurisdiction of which the Company or the Guarantor, as applicable, is subject by a suit upon such
judgment. 
 (e)        Waiver of Jury Trial. Each of the parties hereto hereby waives any
right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. 

(f)        Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. 

(g)        Amendments or Waivers. No amendment or waiver of any provision of this Agreement,
nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. 

(h)        Headings. The headings herein are included for convenience of reference only and are
not intended to be part of, or to affect the meaning or interpretation of, this Agreement. 

(i)        Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III
of Pub. L. 107-56 (signed into law October 26, 2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective clients, including the Company, which
information may include the name and address of their 

  
 30 

 respective clients, as well as other information that will allow the Initial Purchasers to properly identify
their respective clients. 
 [Remainder of this page intentionally left blank] 

 If the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by
signing in the space provided below. 
  

			
	Very truly yours,
	
	NAVISTAR INTERNATIONAL CORPORATION
		
	By:    	 	 /s/ Walter G. Borst

		 	Name:  Walter G. Borst
		 	Title:    Executive Vice President and
		 	             Chief Financial Officer
	
	NAVISTAR, INC.
		
	By:	 	 /s/ Walter G. Borst

		 	Name:  Walter G. Borst
		 	Title:    Executive Vice President and
		 	             Chief Financial Officer

 [Signature Page to Purchase Agreement] 

 The foregoing Purchase Agreement is hereby 

confirmed and accepted as of the date first above 
 written. 

J.P. MORGAN SECURITIES LLC 
 For itself and on behalf of the

 several Initial Purchasers listed 
 in Schedule 1 hereto.

  

			
	By:    	 	/s/ Lauren Tanenbaum
		 	Name: Lauren Tanenbaum
		 	Title:   Vice President

 [Signature Page to Purchase Agreement] 

 Schedule 1 
  

					
	 Initial Purchaser
	  	Principal Amount  
of Securities  
		
	 J.P. Morgan Securities LLC
	  	 	$462,000,000  	 
		
	 Goldman Sachs & Co. LLC
	  	 	$198,000,000  	 
		
	 Citigroup Global Markets Inc.
	  	 	$198,000,000  	 
		
	 Deutsche Bank Securities Inc.
	  	 	$198,000,000  	 
		
	 Credit Suisse Securities (USA) LLC
	  	 	$22,000,000  	 
		
	 Guggenheim Securities, LLC
	  	 	$22,000,000  	 
		  	  
	  
	  

		
	 Total
	  	 	$1,100,000,000  	 

 Annex A 

Additional Time of Sale Information 

1.        Pricing term sheet containing the terms of the Securities, dated November 2, 2017, substantially in the
form of Annex B (the “Pricing Supplement”). 

  
 A-1 

 Annex B 

Pricing Term Sheet 

[See attached] 

  
 B-1 

 Annex C 

Restrictions on Offers and Sales Outside the United States 

In connection with offers and sales of Securities outside the United States: 

(a)        Each Initial Purchaser acknowledges that the Securities have not been registered under the
Securities Act and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in transactions not subject to, the registration requirements of the Securities
Act. 
 (b)        Each Initial Purchaser, severally and not jointly, represents, warrants and
agrees that: 
 (i)        Such Initial Purchaser has offered and sold the
Securities, and will offer and sell the Securities, (A) as part of their distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the Closing Date, only in
accordance with Regulation S under the Securities Act (“Regulation S”) or Rule 144A or any other available exemption from registration under the Securities Act. 

(ii)        None of such Initial Purchaser or any of its affiliates or any other
person acting on its or their behalf has engaged or will engage in any directed selling efforts with respect to the Securities, and all such persons have complied and will comply with the offering restrictions requirement of Regulation S. 

(iii)        At or prior to the confirmation of sale of any Securities sold in
reliance on Regulation S, such Initial Purchaser will have sent to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities from it during the distribution compliance period a
confirmation or notice to substantially the following effect: 
 The Securities covered hereby have not been registered under the U.S.
Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (i) as part of their distribution at any time or
(ii) otherwise until 40 days after the later of the commencement of the offering of the Securities and the date of original issuance of the Securities, except in accordance with Regulation S or Rule 144A or any other available exemption from
registration under the Securities Act. Terms used above have the meanings given to them by Regulation S. 

  
 C-1 

 (iv)        Such Initial Purchaser has
not and will not enter into any contractual arrangement with any distributor with respect to the distribution of the Securities, except with its affiliates or with the prior written consent of the Company. 

Terms used in paragraph (a) and this paragraph (b) and not otherwise defined in this Agreement have the meanings given to them by Regulation S. 

  
 C-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]